GENE ONLINE|News &
Opinion
Blog

Reed Slater

WRITTEN BY Reed Slater

CDC Calls an End to J&J’s COVID-19 Vaccine in the U.S.
2023-05-25
FDA Approves Astellas’ Non-hormonal Menopause Treatment After Extended Review
2023-05-19
Angelini Pledges Over $500 Million in Biobucks for JCR’s Epilepsy Therapy Tech
2023-05-11
Novavax, Takeda, and BMS To Cut Employees This Year
2023-05-10
Gilead’s HDV Drug Headed Towards European Approval Even With FDA Rejection
2023-05-08
J&J Puts Up $245 Million for Two Promising Autologous CAR-T Candidates
2023-05-05
Ascendis’ Hormone Drug Hits Another FDA Roadblock on Path to Approval
2023-05-02
Pfizer Racks Up Infant Indication for Pneumococcal Vaccine
2023-05-01
Nestle and Seres Land First-Ever Fecal Microbiota Product Approval From FDA
2023-04-27
FDA Grants Biogen’s Ultra-Rare ALS Med Accelerated Approval
2023-04-26
Novartis Lays Down $40 Million for 3BP’s FAP-Targeting Oncology Tech
2023-04-24
Boehringer to Leverage RetinAI’s AI Tech to Further Geographic Atrophy Research
2023-04-23
Roche Could Set New DLBCL Treatment Standard with First-Line Polivy Indication
2023-04-19
Gamida’s Allogeneic Cell Therapy Snags FDA Approval for Blood Cancers
2023-04-18
Moderna’s Cancer Vaccine to Enter Phase 3 Trials This Year
2023-04-17
1 2 3 … 15
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2025 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top